402 related articles for article (PubMed ID: 25435121)
41. Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.
Parodi F; Passoni L; Massimo L; Luksch R; Gambini C; Rossi E; Zuffardi O; Pistoia V; Pezzolo A
OMICS; 2011 Mar; 15(3):113-21. PubMed ID: 21319993
[TBL] [Abstract][Full Text] [Related]
42. Current Management of Neonatal Neuroblastoma.
Interiano RB; Davidoff AM
Curr Pediatr Rev; 2015; 11(3):179-87. PubMed ID: 26168943
[TBL] [Abstract][Full Text] [Related]
43. Too many targets, not enough patients: rethinking neuroblastoma clinical trials.
Fletcher JI; Ziegler DS; Trahair TN; Marshall GM; Haber M; Norris MD
Nat Rev Cancer; 2018 Jun; 18(6):389-400. PubMed ID: 29632319
[TBL] [Abstract][Full Text] [Related]
44. Neuroblastoma.
Chung C; Boterberg T; Lucas J; Panoff J; Valteau-Couanet D; Hero B; Bagatell R; Hill-Kayser CE
Pediatr Blood Cancer; 2021 May; 68 Suppl 2(Suppl 2):e28473. PubMed ID: 33818884
[TBL] [Abstract][Full Text] [Related]
45. New Approaches Towards Targeted Therapy for Childhood Neuroblastoma.
Dalianis T; Lukoseviciute M; Holzhauser S; Kostopoulou ON
Anticancer Res; 2023 Sep; 43(9):3829-3839. PubMed ID: 37648295
[TBL] [Abstract][Full Text] [Related]
46. Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets.
Katta SS; Nagati V; Paturi ASV; Murakonda SP; Murakonda AB; Pandey MK; Gupta SC; Pasupulati AK; Challagundla KB
J Control Release; 2023 May; 357():444-459. PubMed ID: 37023798
[TBL] [Abstract][Full Text] [Related]
47. Current management of neuroblastoma and future direction.
Pastor ER; Mousa SA
Crit Rev Oncol Hematol; 2019 Jun; 138():38-43. PubMed ID: 31092383
[TBL] [Abstract][Full Text] [Related]
48. Biology and treatment of neuroblastoma.
Castleberry RP
Pediatr Clin North Am; 1997 Aug; 44(4):919-37. PubMed ID: 9286292
[TBL] [Abstract][Full Text] [Related]
49. Genetic predisposition and chromosome instability in neuroblastoma.
Tonini GP; Capasso M
Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
[TBL] [Abstract][Full Text] [Related]
50. Update on neuroblastoma.
Newman EA; Abdessalam S; Aldrink JH; Austin M; Heaton TE; Bruny J; Ehrlich P; Dasgupta R; Baertschiger RM; Lautz TB; Rhee DS; Langham MR; Malek MM; Meyers RL; Nathan JD; Weil BR; Polites S; Madonna MB;
J Pediatr Surg; 2019 Mar; 54(3):383-389. PubMed ID: 30305231
[TBL] [Abstract][Full Text] [Related]
51. Neuroblastoma update.
Henry MC; Tashjian DB; Breuer CK
Curr Opin Oncol; 2005 Jan; 17(1):19-23. PubMed ID: 15608507
[TBL] [Abstract][Full Text] [Related]
52. Neuroblastoma: An Updated Review on Biology and Treatment.
Mallepalli S; Gupta MK; Vadde R
Curr Drug Metab; 2019; 20(13):1014-1022. PubMed ID: 31878853
[TBL] [Abstract][Full Text] [Related]
53. Neuroblastoma.
Davidoff AM
Semin Pediatr Surg; 2012 Feb; 21(1):2-14. PubMed ID: 22248965
[TBL] [Abstract][Full Text] [Related]
54. Genetic discoveries and treatment advances in neuroblastoma.
Bagatell R; Cohn SL
Curr Opin Pediatr; 2016 Feb; 28(1):19-25. PubMed ID: 26576010
[TBL] [Abstract][Full Text] [Related]
55. A finite mixture survival model to characterize risk groups of neuroblastoma.
Hunsberger S; Albert PS; London WB
Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977
[TBL] [Abstract][Full Text] [Related]
56. Narrative review: precision medicine applications in neuroblastoma-current status and future prospects.
Zhou J; Du H; Cai W
Transl Pediatr; 2024 Jan; 13(1):164-177. PubMed ID: 38323175
[TBL] [Abstract][Full Text] [Related]
57. Genetic susceptibility to neuroblastoma: current knowledge and future directions.
Ritenour LE; Randall MP; Bosse KR; Diskin SJ
Cell Tissue Res; 2018 May; 372(2):287-307. PubMed ID: 29589100
[TBL] [Abstract][Full Text] [Related]
58. Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis.
Ognibene M; De Marco P; Amoroso L; Cangelosi D; Zara F; Parodi S; Pezzolo A
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046696
[TBL] [Abstract][Full Text] [Related]
59. Nervous system: Embryonal tumors: Neuroblastoma.
Pudela C; Balyasny S; Applebaum MA
Atlas Genet Cytogenet Oncol Haematol; 2020 Jul; 24(7):284-290. PubMed ID: 32296467
[TBL] [Abstract][Full Text] [Related]
60. Advances in the Management of Neuroblastoma.
Qadir MI; Ahmed B; Noreen S
Crit Rev Eukaryot Gene Expr; 2024; 34(2):1-13. PubMed ID: 38073438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
